Acorn Capital Advisors, LLC Top Holdings and 13F Report (2025) About Acorn Capital Advisors, LLCInvestment ActivityAcorn Capital Advisors, LLC has $152.89 million in total holdings as of June 30, 2025.Acorn Capital Advisors, LLC owns shares of 21 different stocks, but just 10 companies or ETFs make up 80% of its holdings.Approximately 5.74% of the portfolio was purchased this quarter.About 14.85% of the portfolio was sold this quarter.This quarter, Acorn Capital Advisors, LLC has purchased 22 new stocks and bought additional shares in 7 stocks.Acorn Capital Advisors, LLC sold shares of 5 stocks and completely divested from 1 stock this quarter.Largest Holdings CG ONCOLOGY INC $29,419,026Urogen Pharma $17,258,560Y-mAbs Therapeutics $15,419,668Puma Biotechnology $14,170,354Candel Therapeutics $13,057,416 Largest Purchases this Quarter ONKURE THERAPEUTICS INC 1,400,000 shares (about $3.35M)Candel Therapeutics 428,265 shares (about $2.17M)Protara Therapeutics 472,315 shares (about $1.43M)Y-mAbs Therapeutics 183,608 shares (about $828.07K)Puma Biotechnology 191,247 shares (about $655.98K) Largest Sales this Quarter X4 Pharmaceuticals 7,156,920 shares (about $13.60M)Urogen Pharma 256,554 shares (about $3.51M)MURAL ONCOLOGY PLC 615,936 shares (about $1.52M)Cardiff Oncology 33,541 shares (about $105.65K)VYNE Therapeutics 49,366 shares (about $81.45K) Sector Allocation Over TimeMap of 500 Largest Holdings ofAcorn Capital Advisors, LLC Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorCG ONCOLOGY INC$29,419,0260.0%1,131,50119.2%COMURGNUrogen Pharma$17,258,560$3,514,790 ▼-16.9%1,259,74911.3%MedicalYMABY-mAbs Therapeutics$15,419,668$828,072 ▲5.7%3,418,99510.1%MedicalPBYIPuma Biotechnology$14,170,354$655,977 ▲4.9%4,131,2999.3%MedicalCADLCandel Therapeutics$13,057,416$2,167,021 ▲19.9%2,580,5178.5%MedicalTRVITrevi Therapeutics$11,732,2960.0%2,144,8447.7%MedicalTERNTerns Pharmaceuticals$7,352,8150.0%1,971,2644.8%MedicalONKURE THERAPEUTICS INC$6,786,821$3,346,000 ▲97.2%2,839,6744.4%CLASS A COMCYBIN INC$6,161,5580.0%734,3944.0%COM NEWBICARA THERAPEUTICS$5,977,0100.0%643,3823.9%COMTARAProtara Therapeutics$5,308,909$1,431,115 ▲36.9%1,752,1153.5%MedicalCRDFCardiff Oncology$4,437,616$105,654 ▼-2.3%1,408,7672.9%MedicalAURAAura Biosciences$3,729,357$32,777 ▲0.9%595,7442.4%MedicalVSTMVerastem$3,234,9170.0%779,4982.1%MedicalAADIAadi Bioscience$2,130,6090.0%1,139,3631.4%MedicalBCABBioAtla$1,914,704$318,014 ▲19.9%4,835,1111.3%MedicalMURAL ONCOLOGY PLC$1,614,834$1,521,362 ▼-48.5%653,7791.1%COMVYNEVYNE Therapeutics$1,215,344$81,454 ▼-6.3%736,5720.8%MedicalQ32 BIO INC.$1,197,1030.0%803,4250.8%COMACRVAcrivon Therapeutics$482,2320.0%405,2370.3%MedicalXFORX4 Pharmaceuticals$292,087$13,598,148 ▼-97.9%153,7300.2%MedicalOPTINOSE INC$0$3,877,202 ▼-100.0%00.0%COM NEWShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access